Physician profile
Sami Kabbara
NPI 1609372366
$4,243.16
in general payments reported to CMS, 2019-2025
12 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $368 · 2021: $2,268 · 2022: $803 · 2023: $188 · 2024: $155 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,102.66 | 2019-2021 | |
| Alcon Vision LLC | $935.61 | 2021-2023 | Constellation |
| Glaukos Corporation | $363.28 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $135.66 | 2020 | |
| Horizon Therapeutics Plc | $125.67 | 2020 | |
| Amgen INC. | $114.43 | 2025 | Tepezza |
| Abbvie INC. | $112.78 | 2025 | |
| Bausch & Lomb Americas INC. | $110.02 | 2024 | Stellaris |
| Allergan, INC. | $99.99 | 2019 | |
| Omeros Corporation | $71.37 | 2020 | |
| Dutch Ophthalmic, USA | $44.83 | 2024 | Eva, Combined Machine, Tissueblue |
| Harrow Eye, LLC | $26.86 | 2025 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Kabbara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.